We are using cutting-edge, AI-driven technology, combined with low-cost smartphone hardware to help prevent vision loss. Over 400 million patients worldwide are susceptible to diseases that lead to blindness which could be prevented like diabetes, glaucoma, macular degeneration, and several others. Through our patented and FDA-cleared camera, we aim to significantly lower the cost and complexity of diagnosis with a single retinal image. Because of the unique nature of this picture, which is effectively a non-invasive biopsy of the brain and its blood vessels, we plan to leverage this data set for proprietary analytics and risk prediction of many catastrophic or chronic diseases.

An ex-Stanford team out of Y Combinator’s Summer 2017 batch, we are backed by both well regarded institutional investors and industry leaders. We are bringing the eye specialist’s exam and expertise to your primary care doctor’s office, and in doing so, we are striving to improve how healthcare is provided on a global scale.